CRYSTALLINE β-MODIFICATION OF 3-(4-AMINO-1-OXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL)-PIPERIDINE-2,6-DIONE, METHOD OF ITS PRODUCTION AND PHARMACEUTICAL COMPOSITION BASED THEREON Russian patent published in 2017 - IPC C07D401/04 A61K31/445 A61P35/00 

Abstract RU 2616976 C1

FIELD: pharmacology.

SUBSTANCE: invention relates to a new crystalline modification of 3-(4-amino-1-oxo-1,3-dihydro-2H-isoindol-2-yl)-piperidine-2,6-dione (lenalidomide is an international non-proprietary name) - β-modification, characterized by the following set of interplanar distances (d, Å) and corresponding intensities (Irel., %): 12.358 - 8.39%; 11.893 - 29.79%; 11.551 - 100.00%; 8.606 - 8.39%; 7.641 - 4.62%; 7.024 - 8.05%; 5.927 - 8.05%; 5.811 - 19.86%; 5.262 - 28.42%; 5.117 - 9.42%; 4.850 - 5.99%; 4.595 - 5.99%; 4.215 - 10.45%; 4.011 - 6.68%; 3.948 - 11.47%; 3.877 - 51.88%; 3.843 - 39.73%; 3.698 - 16.44%; 3.426 - 6.51%; 3.316 - 4.97%; 3.201 - 5.14%; 3.103 - 4.45%; 3.025 - 3.42%; 2.989 - 2.91%; 2.905 - 9.93%; 2.846 - 5.99%; 2.826-5.65%; 2.702 - 10.27%; 2.640 - 7.88%; 2.555 - 10.27%; 2.478 - 7.19%; 2.339 - 6.51%; 2.647 - 23.12%; 2.282 - 11.82%; 2.243 - 9.93%; 2.168 - 5.82%; 2.107 - 9.08%; 2.081 - 7.36%; 2.066 - 10.96%; 2.027 - 9.76%; 1.943 - 5.65%; 1.912 - 24.83%; 1.795 - 4.45%; 1.719 - 4.62%; 1.694 - 5.72%; 1.659 - 7.19%; 1.634 - 3.94% and DSC curve with two thermal effects: exothermic effect at temperature (174.9±0.5)°C and endothermic effect at a temperature of (267.7±0.5)°C. As well as to a method for its preparation and use in the pharmaceutical industry and medicine as a representative of a new class of immunomodulators possessing both immunomodulatory and anti-angiogenic properties for multiple myeloma treatment.

EFFECT: increased efficiency of composition application.

4 cl, 4 tbl, 6 dwg, 4 ex

Similar patents RU2616976C1

Title Year Author Number
WEAKLY CRYSTALLISED β-MODIFICATION OF (S)-ISOPROPYL 2-((S)-(((2R,3R,4R,5R)-5-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-(2H)-YL)-4-FLUORO-3-HYDROXY-4-METHYLTETRAHYDROFURAN-2-YL)METHOXY)-(PHENOXY)PHOSPHORYLAMINO)PROPANOATE, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION BASED THEREON 2017
  • Mikhajlov Oleg Rostislavovich
  • Uvarov Nikolaj Aleksandrovich
  • Malin Aleksandr Aleksandrovich
RU2656228C9
CRYSTALLINE H-MODIFICATION OF 2-AMINO-2-(2-(4-OCTYLPHENYL) ETHYL)PROPANE-1,3-DIOLE HYDROCHLORIDE, METHOD FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITION BASED THEREON 2016
  • Mikhajlov Oleg Rostislavovich
  • Uvarov Nikolaj Aleksandrovich
  • Malin Aleksandr Aleksandrovich
RU2627691C1
CRYSTALLINE γ-MODIFICATION OF N-{3-CHLORO-4-[(3-FLUOROBENZYL)OXY]PHENYL}-6-[5-({[2-(METHYLSULFONYL)ETHYL]AMINO}METHYL)-2-FURYL]-4-QUINOLINE AMINE OF BIS (4-METHYLBENZENESULFONATE) MONOHYDRATE, METHOD OF ITS PRODUCTION AND PHARMACEUTICAL COMPOSITION BASED THEREON 2016
  • Mikhajlov Oleg Rostislavovich
  • Uvarov Nikolaj Aleksandrovich
  • Malin Aleksandr Aleksandrovich
RU2603943C1
CRYSTALLINE β-MODIFICATION OF N-(3-ETHYLPHENYL)-6,7-BIS(2 METHOXYETHOXY)QUINAZOLINE-4-AMINE HYDROCHLORIDE, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION BASED THEREON 2015
  • Mikhajlov Oleg Rostislavovich
  • Uvarov Nikolaj Aleksandrovich
  • Malin Aleksandr Aleksandrovich
RU2610337C1
CRYSTALLINE γ-MODIFICATION (1α,2β,4β,5α,7β)-7-[(HYDROXYDI-2-THIENYLACETYL)OXY]-9,9-DIMETHYL-3-OXA-9-AZONIATRICYCLO[3,3,1,0]NONANE BROMIDE MONOHYDRATE, METHOD OF THEREOF OBTAINING AND THEREOF-BASED PHARMACEUTICAL COMPOSITION 2015
  • Mikhajlov Oleg Rostislavovich
  • Uvarov Nikolaj Aleksandrovich
  • Malin Aleksandr Aleksandrovich
RU2567539C1
CRYSTAL BETA-MODIFICATION OF (E)-DIMETHYL BUTENEDIOATE, METHOD FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION ON ITS BASIS 2016
  • Mikhajlov Oleg Rostislavovich
  • Uvarov Nikolaj Aleksandrovich
  • Malin Aleksandr Aleksandrovich
RU2616605C1
CRYSTALLINE β-MODIFICATION OF 4-[4-({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]CARBAMOYL}AMINO)PHENOXY]-N-METHYL-PYRIDINE-2-CARBOXAMIDE OF p-TOLUENE SULPHONATE, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION BASED THEREON 2015
  • Mikhajlov Oleg Rostislavovich
  • Uvarov Nikolaj Aleksandrovich
  • Malin Aleksandr Aleksandrovich
RU2568638C1
CRYSTALLINE ANHYDROUS γ-MODIFICATION OF 4-(3'-CHLOR-4'-FLUORANILINO)-7-METHOXY-6-(3-MORPHOLINOPROPOXY)QUINAZOLINE, METHOD FOR PRODUCING IT AND BASED PHARMACEUTICAL COMPOSITION 2014
  • Malin Aleksandr Aleksandrovich
  • Mikhajlov Oleg Rostislavovich
  • Uvarov Nikolaj Aleksandrovich
RU2577518C2
NANO-AMORPHOUS FORM (RS)-3-(4-AMINO-1-OXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL)PIPERIDINE-2,6-DIONE (VERSIONS), A METHOD FOR PRODUCTION THEREOF AND USE FOR TREATING IMMUNOLOGICAL OR ONCOLOGICAL DISEASES 2019
  • Torchinov Georgij Yur'Evich
RU2723624C1
CRYSTALLINE ε-MODIFICATION OF N-[2-(DIETHYLAMINO)ETHYL]-5-[(Z)-(5-FLUOR-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)METHYL]-2,4-DIMETHYL-1H-PYRROL-3-CARBOXAMIDE MALATE, METHOD FOR PRODUCING SAME AND BASED PHARMACEUTICAL COMPOSITION 2014
  • Malin Aleksandr Aleksandrovich
  • Mikhajlov Oleg Rostislavovich
  • Uvarov Nikolaj Aleksandrovich
RU2567535C1

RU 2 616 976 C1

Authors

Mikhajlov Oleg Rostislavovich

Uvarov Nikolaj Aleksandrovich

Malin Aleksandr Aleksandrovich

Dates

2017-04-19Published

2016-04-07Filed